We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Teladoc (TDOC) Q1 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Teladoc (TDOC - Free Report) to post quarterly loss of $0.33 per share in its upcoming report, which indicates a year-over-year increase of 32.7%. Revenues are expected to be $617.67 million, down 4.4% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Teladoc metrics that are commonly monitored and projected by Wall Street analysts.
Analysts expect 'Revenues by Segment- BetterHelp' to come in at $237.29 million. The estimate suggests a change of -11.8% year over year.
The collective assessment of analysts points to an estimated 'Revenues by Segment- Teladoc Health Integrated Care' of $380.91 million. The estimate points to a change of +1% from the year-ago quarter.
The consensus among analysts is that 'Revenues by Segment- BetterHelp- Therapy Services' will reach $231.85 million. The estimate indicates a year-over-year change of -12.1%.
Analysts predict that the 'Revenues by Segment- BetterHelp- Other Wellness Services' will reach $5.87 million. The estimate points to a change of +10.5% from the year-ago quarter.
The consensus estimate for 'Revenue by Type- Access fees' stands at $533.56 million. The estimate suggests a change of -4.2% year over year.
The combined assessment of analysts suggests that 'Revenue by Type- Other' will likely reach $84.31 million. The estimate points to a change of -5.2% from the year-ago quarter.
Analysts' assessment points toward 'U.S. Integrated Care Members' reaching 101.30 million. The estimate compares to the year-ago value of 91.8 million.
According to the collective judgment of analysts, 'Adjusted EBITDA- BetterHelp' should come in at $7.93 million. The estimate compares to the year-ago value of $15.47 million.
Based on the collective assessment of analysts, 'Adjusted EBITDA- Teladoc Health Integrated Care' should arrive at $46.02 million. The estimate compares to the year-ago value of $47.67 million.
Shares of Teladoc have experienced a change of -11% in the past month compared to the -4.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), TDOC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling Teladoc (TDOC) Q1 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts expect Teladoc (TDOC - Free Report) to post quarterly loss of $0.33 per share in its upcoming report, which indicates a year-over-year increase of 32.7%. Revenues are expected to be $617.67 million, down 4.4% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Teladoc metrics that are commonly monitored and projected by Wall Street analysts.
Analysts expect 'Revenues by Segment- BetterHelp' to come in at $237.29 million. The estimate suggests a change of -11.8% year over year.
The collective assessment of analysts points to an estimated 'Revenues by Segment- Teladoc Health Integrated Care' of $380.91 million. The estimate points to a change of +1% from the year-ago quarter.
The consensus among analysts is that 'Revenues by Segment- BetterHelp- Therapy Services' will reach $231.85 million. The estimate indicates a year-over-year change of -12.1%.
Analysts predict that the 'Revenues by Segment- BetterHelp- Other Wellness Services' will reach $5.87 million. The estimate points to a change of +10.5% from the year-ago quarter.
The consensus estimate for 'Revenue by Type- Access fees' stands at $533.56 million. The estimate suggests a change of -4.2% year over year.
The combined assessment of analysts suggests that 'Revenue by Type- Other' will likely reach $84.31 million. The estimate points to a change of -5.2% from the year-ago quarter.
Analysts' assessment points toward 'U.S. Integrated Care Members' reaching 101.30 million. The estimate compares to the year-ago value of 91.8 million.
According to the collective judgment of analysts, 'Adjusted EBITDA- BetterHelp' should come in at $7.93 million. The estimate compares to the year-ago value of $15.47 million.
Based on the collective assessment of analysts, 'Adjusted EBITDA- Teladoc Health Integrated Care' should arrive at $46.02 million. The estimate compares to the year-ago value of $47.67 million.
View all Key Company Metrics for Teladoc here>>>
Shares of Teladoc have experienced a change of -11% in the past month compared to the -4.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), TDOC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>